Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KOrean Precision Medicine Networking Group Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II

NCT05525858 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.

NCT NCT05525858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05525858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KOrean Precision Medicine Networking Group Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
Lead sponsor
Seoul National University Bundang Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
September 28, 2022
Completion date
March 31, 2027
Enrollment
1,000 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, metastatic cancer, solid tumor